Inauguration of the NIMR Biobank Advisory Board Members.
Inauguration of the NIMR Biobank Advisory Board Members
5-Day Intensive Training Workshop on Neglected Bacteriological Procedures
STEPS FOR Center for Infectious Diseases Research, Microbiology Department, Nigerian Institute of Medical Research,
2024 TRAINING PAYMENT
- Go to www.remita.net
- Click on pay TSA and States
- Click on FGN; Federal Government of Nigeria
- In the space for “Who do you want to pay”, input NIGERIAN INSTITUTE OF MEDICAL RESEARCH
- In the space for “Name of Service or Purpose”, choose OI (OTHER INCOME)
- In the space for description, input CIDR 2024 TRAINING
- Input the amount to pay (#50,000)
- Fill in your details (Name, Number and Email)
- Click on submit
- Select the payment method you wish to use.
- Send your evidence of payment to the contact email for confirmation of payment
Sightsavers Courtesy Visit
Dr. Joy Shu’aibu
Country Director
Sightsavers paid a courtesy visit to NIMR.
Emory-Nigeria HIV Research Training Program (EN-RTP) 2024
Programme Objective
The overarching goal of the Emory-Nigeria HIV Research Training Program (EN-RTP) is to enhance the capacity of researchers focused on HIV/women’s health research in Nigeria, with the aim of promoting health and wellbeing for women living with HIV. It leverages the existing partnership between Emory University in Atlanta, Georgia, USA, and three institutions in Lagos, Nigeria.
Eligible Institutions
- Nigerian Institute of Medical Research (NIMR) and affiliates
- University of Lagos (UNILAG)
- AIDS Prevention Initiative Nigeria (APIN)
Trainees
The EN-RTP offers long-, medium-, and short-term training of emerging investigators, facilitating their acquisition of the skills needed to pursue an independent research career. Below is a list of each training track and the requirements to apply:
Sample Documents
- Mentorship Agreement_D43 2024_Final
- sample_Thomas.Rikki.CITI.Biomedical
- sample_Thomas.Rikki.EN-RTP budget_Final (1)-merged
- sample_Thomas.Rikki.HumanSubjects
- Sample_Thomas.Rikki.LiteratureCitations
- sample_Thomas.Rikki.LOS.LeadMentor
- sample_Thomas.Rikki.Mentorship Agreement_D43 2024 (2)
- Sample_Thomas.Rikki.ResearchTrainingPlan
- sample_Thomas_Rikki_Biosketch
- sample_Thomas_Rikki_CoverLetter
- Thomas.Rikki.LOS.DeptChair
SARMAAN II Advert
Safety and Antimicrobial Resistance of Mass Administration of Azithromycin in Children 1-59 months in Nigeria (SARMAAN II) is the second phase of child survival implementation research ongoing in seven (7) states of the country and conducted by the Nigerian Institute of Medical Research, Lagos.
In order to effectively fulfil the objectives of the expansion, we seek dedicated, self-motivated, team players to join our dynamic team: